goglides.dev
ResearchFinanceTechCompaniesDiscussion
Search
Sign inJoin
goglidesgoglides.devSocial learning for Finance and Tech.
TermsPrivacyDisclaimerModerationAcceptable UseDMCAContact
Company / Finance

Zimmer Biomet Holdings, Inc.

ZBH · NYSE

ZBH has an annual revenue baseline of $8.2B, latest revenue marker of $2.1B Q1 2026, annual net income of $705.1M and cash of $424.2M. The thesis depends on revenue durability, margins, cash conversion and balance-sheet discipline.

FollowAdd to WatchlistAsk Question
NYSEZBHCoverage BootstrapZimmer Biomet Holdings, Inc.
OverviewFinancialsResearchTimelineCompareValuationScorecardDiscussion
Latest ReportMay 20, 2026Zimmer Biomet: medtech durability still has to prove procedure demand, margin quality and cash conversionView report ->Total Reports1Published reportView all ->Active Discussions0No visible comments yetView discussions ->Member WorkspaceLockedFinancials, timeline, comparisons, scorecard, and discussion require a paid login.View access ->
Admin-only preview

Valuation is limited to admins for now.

The valuation workbench is hidden from non-admin users until market-data licensing and trust disclosures are production-ready.

Sign in as admin